Literature DB >> 743835

Eight year results of Charnley arthroplasties of the hip with special reference to the behavior of cement.

M J Griffith, M K Seidenstein, D Williams, J Charnley.   

Abstract

Five hundred and forty-seven total hip replacements by the Charnley technique during 1967 and 1968 have been studied for the quality of the late results. The average follow-up was 8.3 years. Mechanical failure at the cement-bone interface occurred in only 2.2% of cases. A search was specially directed towards evidence of incipient pathology at the bone-cement interface in the absence of any suspicion of clinical defect. This was found in 12% of cases but it is emphasized that the criteria were exceptionally rigorous and entirely radiological. Because the cement technology used at that time is now considered unsophisticated, mechanical failure of cement is a preventable condition. A previous report of socket migration in 9.5% of cases is not confirmed by the present survey of a more recent series of cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743835

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Uncoated polyethylene RM acetabular component versus Müller cemented acetabular component. A 4- to 8-year follow-up study.

Authors:  M Krismer; M Fischer; T Klestil; B Frischhut
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

2.  Aseptic loosening of cement-anchored total hip replacements.

Authors:  G Aldinger; J Gekeler
Journal:  Arch Orthop Trauma Surg       Date:  1982

3.  Does age or bilateral disease influence the value of hip arthroplasty?

Authors:  Bryan M Lawless; Meridith Greene; James Slover; Young-Min Kwon; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

4.  The Relative Merits of Cemented and Uncemented Prostheses in Total Hip Arthroplasty.

Authors:  Joanna Maggs; Matthew Wilson
Journal:  Indian J Orthop       Date:  2017 Jul-Aug       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.